[HTML][HTML] Benzbromarone aggravates hepatic steatosis in obese individuals
P Sun, JJ Zhu, T Wang, Q Huang, YR Zhou… - … et Biophysica Acta (BBA …, 2018 - Elsevier
As a widely used anti-gout drug, benzbromarone has been found to induce hepatic toxicity
in patients during clinical treatment. Previous studies have reported that benzbromarone is …
in patients during clinical treatment. Previous studies have reported that benzbromarone is …
[引用][C] Benzbromarone aggravates hepatic steatosis in obese individuals
P Sun, JJ Zhu, T Wang, Q Huang, YR Zhou… - … et Biophysica Acta …, 2018 - cir.nii.ac.jp
Benzbromarone aggravates hepatic steatosis in obese individuals
P Sun, JJ Zhu, T Wang, Q Huang… - … et biophysica acta …, 2018 - pubmed.ncbi.nlm.nih.gov
As a widely used anti-gout drug, benzbromarone has been found to induce hepatic toxicity
in patients during clinical treatment. Previous studies have reported that benzbromarone is …
in patients during clinical treatment. Previous studies have reported that benzbromarone is …
Benzbromarone aggravates hepatic steatosis in obese individuals.
P Sun, JJ Zhu, T Wang, Q Huang, YR Zhou… - … et Biophysica acta …, 2018 - europepmc.org
As a widely used anti-gout drug, benzbromarone has been found to induce hepatic toxicity
in patients during clinical treatment. Previous studies have reported that benzbromarone is …
in patients during clinical treatment. Previous studies have reported that benzbromarone is …